Literature DB >> 25435123

Late effects of childhood cancer and its treatment.

Wendy Landier1, Saro Armenian1, Smita Bhatia2.   

Abstract

Treatment for childhood cancer with chemotherapy, radiation and/or hematopoietic cell transplant can result in adverse sequelae that may not become evident for many years. A clear understanding of the association between therapeutic exposures and specific long-term complications, and an understanding of the magnitude of the burden of morbidity borne by childhood cancer survivors, has led to the development of guidelines to support lifelong risk-based follow up for this population. It is important to develop interventions to reduce the impact of treatment-related late effects on morbidity and mortality and to continue research regarding the etiopathogenesis of therapy-related cancers and other late effects.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Childhood; Late effects; Treatment

Mesh:

Substances:

Year:  2014        PMID: 25435123     DOI: 10.1016/j.pcl.2014.09.017

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  20 in total

1.  Influence of selected anti-cancer drugs on the induction of DNA double-strand breaks and changes in gene expression in human hepatoma HepG2 cells.

Authors:  Matjaž Novak; Bojana Žegura; Špela Baebler; Alja Štern; Ana Rotter; Katja Stare; Metka Filipič
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-22       Impact factor: 4.223

2.  Clinical Trial Enrollment is Associated With Improved Follow-up Rates Among Survivors of Childhood Cancer.

Authors:  Kelley K Hutchins; Süreyya Savaşan; Ronald L Thomas; Laura A Strathdee; Zhihong J Wang; Jeffrey W Taub
Journal:  J Pediatr Hematol Oncol       Date:  2019-01       Impact factor: 1.289

3.  Considerations of biomarker application for cancer continuum in the era of precision medicine.

Authors:  Rayjean J Hung; Elham Khodayari Moez; Shana J Kim; Sanjeev Budhathoki; Jennifer D Brooks
Journal:  Curr Epidemiol Rep       Date:  2022-07-09

4.  Social networks of oncology clinicians as a means for increasing survivorship clinic referral.

Authors:  Sarah E Piombo; Kimberly A Miller; David R Freyer; Joel E Milam; Anamara Ritt-Olson; Gino K In; Thomas W Valente
Journal:  Commun Med (Lond)       Date:  2022-07-15

5.  Annual Economic Burden of Productivity Losses Among Adult Survivors of Childhood Cancers.

Authors:  Gery P Guy; Zahava Berkowitz; Donatus U Ekwueme; Sun Hee Rim; K Robin Yabroff
Journal:  Pediatrics       Date:  2016-11       Impact factor: 7.124

6.  Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.

Authors:  L Lee Dupuis; Xiaomin Lu; Hannah-Rose Mitchell; Lillian Sung; Meenakshi Devidas; Leonard A Mattano; William L Carroll; Naomi Winick; Stephen P Hunger; Kelly W Maloney; Nina S Kadan-Lottick
Journal:  Cancer       Date:  2016-01-15       Impact factor: 6.860

7.  Brain structure, working memory and response inhibition in childhood leukemia survivors.

Authors:  Ellen van der Plas; Russell J Schachar; Johann Hitzler; Jennifer Crosbie; Sharon L Guger; Brenda J Spiegler; Shinya Ito; Brian J Nieman
Journal:  Brain Behav       Date:  2016-12-29       Impact factor: 2.708

Review 8.  Targeted therapy for soft tissue sarcomas in adolescents and young adults.

Authors:  Diana A Steppan; Christine A Pratilas; David M Loeb
Journal:  Adolesc Health Med Ther       Date:  2017-03-30

9.  Public Health's Future Role in Cancer Survivorship.

Authors:  Mary C White; Nikki S Hayes; Lisa C Richardson
Journal:  Am J Prev Med       Date:  2015-12       Impact factor: 5.043

10.  Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.

Authors:  Michael A Pulsipher; K Scott Baker; Christine N Duncan; Ruta Brazauskas; Jiaxing Huang; Bronwen E Shaw; Navneet S Majhail; Bipin N Savani; Mary E D Flowers; Minoo Battiwalla; Kristen Beebe; Andrew C Dietz; Christopher C Dvorak; Roger Giller; David A Jacobsohn; Morris Kletzel; Paul L Martin; Eneida R Nemecek; Brandon Nuechterlein; Julie-An Talano
Journal:  Bone Marrow Transplant       Date:  2018-03-26       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.